iring a charge to earnings; (j) the competition we face in our business, including competition related to investment products and fees; (k) our ability to develop new products that are attractive to financial advisers and investors; (l) potential adverse regulatory and legal developments; (m) the difficulty of detecting misconduct by our employees, subadvisers and distribution partners; (n) change